The cost-effectiveness analysis of combination of peginterferon alfa-2a and ribavirin versus combination of peginterferon alfa-2b and ribavirin in chronic hepatitis C in Poland

被引：0
|
作者：
Orlewska, E [1 ]
机构：
[1] Ctr Pharmacoeconom, Warsaw, Poland
来源：
VALUE IN HEALTH | 2004年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)62487-4
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：356 / 356
页数：1
相关论文
共 50 条
  • [41] Peginterferon alfa-2a and peginterferon alfa-2b combined with ribavirin in patients with genotype 1 chronic hepatitis C: Results of a prospective single-centre study
    Berak, Hanna
    Laskus, Tomasz
    Kolakowska-Rzadzka, Anna
    Wasilewski, Marek
    Stanczak, Janusz J.
    Bardadin, Krzysztof
    Walewska-Zielecka, Bozena
    Horban, Andrzej
    ADVANCES IN MEDICAL SCIENCES, 2014, 59 (02): : 261 - 265
  • [42] Peginterferon alfa-2b and Ribavirin: Effective in Patients With Hepatitis C Who Failed Interferon alfa/Ribavirin Therapy
    Poynard, Thierry
    Colombo, Massimo
    Bruix, Jordi
    Schiff, Eugene
    Terg, Ruben
    Flamm, Steven
    Moreno-Otero, Ricardo
    Carrilho, Flair
    Schmidt, Warren
    Berg, Thomas
    McGarrity, Thomas
    Heathcote, E. Jenny
    Goncales, Fernando
    Diago, Moises
    Craxi, Antonio
    Silva, Marcelo
    Bedossa, Pierre
    Mukhopadhyay, Pabak
    Griffel, Louis
    Burroughs, Margaret
    Brass, Clifford
    Albrecht, Janice
    GASTROENTEROLOGY, 2009, 136 (05) : 1618 - 1628
  • [43] Clinical and persistency outcomes in hepatitis C patients treated with peginterfercin alfa-2a or peginterferon alfa-2b plus ribavirin
    Hassanein, Tarek
    Ye, Xin
    Chu, Teng-Chiao
    Brixner, Diana
    GASTROENTEROLOGY, 2008, 134 (04) : A833 - A833
  • [44] Generalized nummular eczema secondary to peginterferon Alfa-2b and ribavirin combination therapy for hepatitis C infection
    Shen, Y
    Pielop, J
    Hsu, S
    ARCHIVES OF DERMATOLOGY, 2005, 141 (01) : 102 - 103
  • [45] Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection (vol 361, pg 580, 2009)
    McHutchison, J. G.
    Lawitz, E. J.
    Shiffman, M. L.
    Muir, A. J.
    Galler, G. W.
    McCone, J.
    Nyberg, L. M.
    Lee, W. M.
    Ghalib, R. H.
    Schiff, E. R.
    Galati, J. S.
    Bacon, B. R.
    Davis, M. N.
    Mukhopadhyay, P.
    Koury, K.
    Noviello, S.
    Pedicone, L. D.
    Brass, C. A.
    Albrecht, J. K.
    Sulkowski, M. S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (10): : 1027 - 1027
  • [46] The cost-effectiveness of peginterferon alfa-2b (12KD) plus ribavirin vs. interferon alfa-2b plus ribavirin for chronic hepatitis C (CHC) in a developing country - Brazil
    Fonseca, MC
    Araujo, GTB
    VALUE IN HEALTH, 2005, 8 (06) : A119 - A120
  • [47] A case of hepatitis C-associated osteosclerosis that was improved with the combination therapy of peginterferon alfa-2b and ribavirin
    Shakado S.
    Akehi Y.
    Yotsumoto K.
    Fukunaga A.
    Kuno S.
    Tanaka T.
    Sakurai K.
    Iwashita H.
    Ueda S.
    Hirano G.
    Yokoyama K.
    Morihara D.
    Nishizawa S.
    Sakamoto M.
    Anan A.
    Takeyama Y.
    Irie M.
    Iwata K.
    Sohda T.
    Sakisaka S.
    Clinical Journal of Gastroenterology, 2011, 4 (4) : 255 - 261
  • [48] Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
    Manns, MP
    McHutchison, JG
    Gordon, SC
    Rustgi, VK
    Shiffman, M
    Reindollar, R
    Goodman, ZD
    Koury, K
    Ling, MH
    Albrecht, JK
    LANCET, 2001, 358 (9286): : 958 - 965
  • [49] Comparison of pegylated interferon alfa-2a and alfa-2b in combination with ribavirin in obese patients with chronic hepatitis
    Moore, CH
    Angtuaco, TL
    Lindsey, JL
    Nelson, SD
    Malik, AH
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S109 - S109
  • [50] Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C
    Wirth, S
    Pieper-Boustani, H
    Lang, T
    Ballauff, A
    Kullmer, U
    Gerner, P
    Wintermeyer, P
    Jenke, A
    HEPATOLOGY, 2005, 41 (05) : 1013 - 1018
12345